Racemic meroterpenoids from Ganoderma cochlear

Fitoterapia. 2018 Jun:127:286-292. doi: 10.1016/j.fitote.2018.03.005. Epub 2018 Mar 11.

Abstract

Ganoderma cochlear, as edible and medicinal fungus, has long been used to prevent and treat various diseases. As our continuously phytochemical investigation of this fungus, a HPLC-UV-guided method led to the isolation of nine previously undescribed aromatic meroterpenoids with different ring systems, including six pairs of racemates, (±)-cochlearins A-E, G (1-5, 7), and three new analogues, cochlearins F, H and I (6, 8, 9). Their structures were elucidated by extensive 1D, 2D NMR spectroscopic data and MS analyses. The stereostructures of (±)-cochlearins A and B (1 and 2) were assigned using electronic circular dichroism (ECD) calculations. All of the isolates showed comparable antioxidant activities with IC50 values of 3.1 ± 0.1-5.3 ± 0.1 μM, compared to the positive control (trolox, IC50: 3.3 ± 0.1 μM). (±)-Cochlearin D (4) and (+)-4 exhibited weak inhibitory effects for the proliferation of hepatic stellate cells (HSCs) induced by transforming growth factor-β1 (TGF-β1).

Keywords: Antioxidant activities; Aromatic meroterpenoids; Ganoderma cochlear; Ganodermataceae; Liver fibrosis.

MeSH terms

  • Cell Line
  • Cell Proliferation / drug effects
  • Ganoderma / chemistry*
  • Hepatic Stellate Cells / drug effects
  • Humans
  • Molecular Structure
  • Monoterpenes / isolation & purification*
  • Transforming Growth Factor beta1

Substances

  • Monoterpenes
  • Transforming Growth Factor beta1